Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×

Product portfolios acquired by Vimian

Vimian Group has acquired the product portfolios of veterinary surgical instruments and orthopaedic implants sold under the brands Spectrum and Everost

Vimian Group has acquired two product portfolios of veterinary surgical instruments and orthopaedic implants in the US. The acquisition marks the entry into a new product category with veterinary surgical instrumentation and expands Vimian’s portfolio of high-quality orthopaedic implants for companion animals. The acquired portfolios have combined annual revenues of around USD 6.5 million.

Vimian Group’s MedTech segment, Movora, has acquired two product portfolios of veterinary surgical instruments and orthopaedic implants sold to veterinary clinics across North America under the brands Spectrum and Everost. The acquisition is a carve-out from a healthcare company.

The acquired portfolios include a wide range of high-quality veterinary orthopaedic implants sold under the brand Everost as well as a broad offering of surgical instruments developed specifically for veterinary applications and sold under the brand Spectrum.

“This acquisition marks our entry into a new product category with veterinary surgical instrumentation and expands our portfolio of high-quality orthopaedic implants,” says Patrick Gendreau, Co-CEO of Vimian’s MedTech segment Movora. “We gain access to a loyal customer base that we can leverage for our entire MedTech offering in the US and foresee significant synergy potential as we integrate these product portfolios into our commercial infrastructure around the world.”

The acquisition has a marginal impact on Vimian’s earnings per share and was consolidated into Vimian’s MedTech segment on 4 April 2022.

Have you heard about our
Membership?

The number one resource for veterinary professionals.

From hundreds of CPD courses to clinical skills videos. There is something for everyone.

Discover more